Henry Ford Health, Behavioral Health, Detroit, Michigan; Henry Ford Health, Center for Health Policy & Health Services Research, Detroit, Michigan.
Wayne State University School of Medicine, Detroit, Michigan.
Surg Obes Relat Dis. 2024 Jan;20(1):91-97. doi: 10.1016/j.soard.2023.09.009. Epub 2023 Sep 11.
There are limited data regarding the association of cannabis use with outcomes after bariatric surgery. As such, it is challenging to know how to counsel patients using cannabis.
The purpose of this study was to examine whether postsurgical cannabis use was associated with psychiatric symptoms and maladaptive eating among individuals up to 4 years after bariatric surgery.
Single health system.
All patients who underwent bariatric surgery over a 4-year period were invited to participate. Participants (N = 765) completed questionnaires online regarding postsurgical cannabis use, psychiatric symptoms, and maladaptive eating.
Any cannabis use after bariatric surgery was associated with increased likelihood of having elevated symptoms of anxiety (odds ratio [OR] = 1.88, P = .003; 37.8% versus 24.4%), increased likelihood of grazing behaviors (OR = 1.77, P = .01; 71.2% versus 58.2%), and higher scores for eating in response to depression (P = .01; 12.13 versus 10.75). Weekly cannabis use was associated with loss of control eating (OR = 1.81, P = .04; 37.2% versus 24.7%), binge eating (OR = 2.16, P = .03; 20.0% versus 10.4%), and night eating behaviors (OR = 2.11, P = .01; 40.0% versus 24.0%). Cannabis use was not associated with depression (P > .05).
Cannabis use after bariatric surgery was associated with anxiety symptoms and engaging in maladaptive eating behaviors. Frequent cannabis use (i.e., ≥1 per week) was associated with additional types of maladaptive eating. Clinicians involved in presurgical and postsurgical care may want to counsel patients currently using cannabis, especially those who are engaging in frequent use.
关于大麻使用与减重手术后结果的关联，数据有限。因此，很难知道如何为使用大麻的患者提供咨询。
本研究旨在探讨减重手术后大麻使用是否与手术后 4 年内个体的精神症状和不良进食行为相关。
单一医疗体系。
所有在 4 年内接受过减重手术的患者均被邀请参与。参与者（N=765）在线完成了关于手术后大麻使用、精神症状和不良进食行为的问卷。
减重手术后任何形式的大麻使用与焦虑症状升高的可能性增加相关（优势比[OR] = 1.88，P =.003；37.8%比 24.4%），暴食行为的可能性增加（OR = 1.77，P =.01；71.2%比 58.2%），以及抑郁时进食的评分更高（P =.01；12.13 比 10.75）。每周使用大麻与失控性进食（OR = 1.81，P =.04；37.2%比 24.7%）、暴食（OR = 2.16，P =.03；20.0%比 10.4%）和夜间进食行为（OR = 2.11，P =.01；40.0%比 24.0%）相关。大麻使用与抑郁无关（P >.05）。
减重手术后大麻使用与焦虑症状和不良进食行为相关。频繁使用大麻（即每周≥1 次）与更多类型的不良进食行为相关。参与术前和术后护理的临床医生可能希望为目前使用大麻的患者提供咨询，特别是那些经常使用大麻的患者。
